9e78bc1d5442afc8c196b483135f078e pmc_35203878.pdf 244b9ef59ef6ebacf897dc935b5d4e178911c8ef pmc_35203878.pdf 7377200ffe820cbb1e466561b8903109061ddd7f9fe9a648c36a27ae559e81d7 pmc_35203878.pdf Title: Safety and Efficacy of Devices Delivering Inhaled Antibiotics among Adults with Non-Cystic Fibrosis Bronchiectasis: A Systematic Review and a Network Meta-Analysis Subject: It remains unknown whether the type of aerosol generating device is affecting efficacy and safety among non-cystic fibrosis bronchiectasis (NCFB) adults. The proposal of this network meta-analysis (NMA) is to evaluate effectiveness and safety of inhaled antibiotics administered via dry powder inhaler (DPI) and via nebulizers (SVN) among adult patients with NCFB. Inclusion criteria were randomized-controlled trials, adults (18 years) with NCFB, and inhaled antibiotics administered via DPI as intervention. Search strategy was performed in PubMed, Web of Science, and Cochrane Library from 2000 to 2019. Sixteen trials (2870 patients) were included. Three trials (all ciprofloxacin) used DPIs and thirteen used SVN (three ciprofloxacin). Both DPI and SVN devices achieved similar safety outcomes (adverse events, antibiotic discontinuation, severe adverse events, and bronchospasm). Administration of ciprofloxacin via DPI significantly improved time to first exacerbation (87 days, 95% CI 34.3–139.7) and quality of life (MD -7.52; 95% CI -13.06 to -1.98) when compared with via SVN. No other significant differences were documented in clinical efficacy (at least one exacerbation, FEV1% predicted) and microbiologic response (bacterial eradication, emergence of new potential pathogens, and emergence of antimicrobial resistance) when comparing devices. Our NMA documented that time to first exacerbation and quality of life, were more favorable for DPIs. Decisions on the choice of devices should incorporate these findings plus other criteria, such as simplicity, costs or maintenance requirements. Keywords: bronchiectasis; non-cystic fibrosis; dry powder inhaled; small-volume nebulizer; inhaled antibiotics Author: Sofia Tejada, Sergio Ramírez-Estrada, Carlos G. Forero, Miguel Gallego, Joan B. Soriano, Pablo A. Cardinal-Fernández, Stephan Ehrmann and Jordi Rello Creator: LaTeX with hyperref Producer: pdfTeX-1.40.21 CreationDate: Tue Feb 22 02:44:23 2022 CET ModDate: Tue Feb 22 02:56:00 2022 CET Tagged: no UserProperties: no Suspects: no Form: none JavaScript: no Pages: 14 Encrypted: no Page size: 595.276 x 841.89 pts (A4) Page rot: 0 File size: 2069536 bytes Optimized: no PDF version: 1.7 name type encoding emb sub uni object ID ------------------------------------ ----------------- ---------------- --- --- --- --------- EIFDAO+VnURWPalladioL Type 1 Custom yes yes no 10 0 QEEQTI+URWPalladioL-Bold Type 1 Custom yes yes no 15 0 NDIIOJ+URWPalladioL-Roma Type 1 Custom yes yes no 20 0 OXVNHD+URWPalladioL-Ital Type 1 Custom yes yes no 24 0 LJEZBI+CMSY10 Type 1 Builtin yes yes no 28 0 SSNIUI+VnURWPalladioL-Bold Type 1 Custom yes yes no 32 0 MCBCCI+SourceSansRoman-Regular Type 1C Custom yes yes no 40 0 MCBCCM+SourceSansRoman.613wght Type 1C Custom yes yes no 44 0 MCBCCO+SourceSansRoman-Bold Type 1C Custom yes yes no 48 0 YYFPCJ+TimesNewRomanPS-BoldItalicMT Type 1C WinAnsi yes yes no 61 0 CIDFont+F3 CID TrueType Identity-H yes no yes 88 0 CIDFont+F1 CID TrueType Identity-H yes no yes 96 0 CIDFont+F2 CID TrueType Identity-H yes no yes 104 0 PYNNNQ+URWPalladioL-BoldItal Type 1 Custom yes yes no 116 0 CIDFont+F3 CID TrueType Identity-H yes no yes 128 0 CIDFont+F1 CID TrueType Identity-H yes no yes 136 0 CIDFont+F2 CID TrueType Identity-H yes no yes 144 0 CIDFont+F5 CID TrueType Identity-H yes no yes 152 0 CIDFont+F3 CID TrueType Identity-H yes no yes 166 0 CIDFont+F1 CID TrueType Identity-H yes no yes 174 0 CIDFont+F2 CID TrueType Identity-H yes no yes 182 0 CIDFont+F4 CID TrueType Identity-H yes no yes 190 0 CIDFont+F5 CID TrueType Identity-H yes no yes 198 0 CIDFont+F3 CID TrueType Identity-H yes no yes 212 0 CIDFont+F1 CID TrueType Identity-H yes no yes 220 0 CIDFont+F2 CID TrueType Identity-H yes no yes 228 0 Jhove (Rel. 1.22.1, 2019-04-17) Date: 2022-03-23 02:23:17 CET RepresentationInformation: pmc_35203878.pdf ReportingModule: PDF-hul, Rel. 1.12.1 (2019-04-17) LastModified: 2022-02-27 18:35:32 CET Size: 2069536 Format: PDF Version: 1.7 Status: Well-Formed and valid SignatureMatches: PDF-hul MIMEtype: application/pdf PDFMetadata: Objects: 435 FreeObjects: 1 IncrementalUpdates: 0 DocumentCatalog: PageLayout: SinglePage PageMode: UseNone Outlines: Item: Title: Introduction Destination: edu.harvard.hul.ois.jhove.module.pdf.PdfSimpleObject@7b69c6ba Item: Title: Results Destination: edu.harvard.hul.ois.jhove.module.pdf.PdfSimpleObject@46daef40 Children: Item: Title: Study Selection Destination: edu.harvard.hul.ois.jhove.module.pdf.PdfSimpleObject@12f41634 Item: Title: Study Characteristics Destination: edu.harvard.hul.ois.jhove.module.pdf.PdfSimpleObject@13c27452 Item: Title: Risk of Bias Assessment Destination: edu.harvard.hul.ois.jhove.module.pdf.PdfSimpleObject@262b2c86 Item: Title: Outcomes Destination: edu.harvard.hul.ois.jhove.module.pdf.PdfSimpleObject@371a67ec Children: Item: Title: Efficacy Destination: edu.harvard.hul.ois.jhove.module.pdf.PdfSimpleObject@5ed828d Item: Title: Microbiological Outcomes Destination: edu.harvard.hul.ois.jhove.module.pdf.PdfSimpleObject@50d0686 Item: Title: Mortality Destination: edu.harvard.hul.ois.jhove.module.pdf.PdfSimpleObject@7a3d45bd Item: Title: Safety Outcomes Destination: edu.harvard.hul.ois.jhove.module.pdf.PdfSimpleObject@1e7c7811 Item: Title: Discussion Destination: edu.harvard.hul.ois.jhove.module.pdf.PdfSimpleObject@77ec78b9 Item: Title: Methods Destination: edu.harvard.hul.ois.jhove.module.pdf.PdfSimpleObject@1a3869f4 Children: Item: Title: Registration and Protocol Destination: edu.harvard.hul.ois.jhove.module.pdf.PdfSimpleObject@a38d7a3 Item: Title: Eligibility Criteria Destination: edu.harvard.hul.ois.jhove.module.pdf.PdfSimpleObject@77f99a05 Item: Title: Search Strategy Destination: edu.harvard.hul.ois.jhove.module.pdf.PdfSimpleObject@63440df3 Item: Title: Data Collection Destination: edu.harvard.hul.ois.jhove.module.pdf.PdfSimpleObject@3aeaafa6 Item: Title: Quality Assessment Destination: edu.harvard.hul.ois.jhove.module.pdf.PdfSimpleObject@76a3e297 Item: Title: Statistical Analysis Destination: edu.harvard.hul.ois.jhove.module.pdf.PdfSimpleObject@4d3167f4 Item: Title: Conclusions Destination: edu.harvard.hul.ois.jhove.module.pdf.PdfSimpleObject@ed9d034 Item: Title: References Destination: edu.harvard.hul.ois.jhove.module.pdf.PdfSimpleObject@6121c9d6 Info: Title: Safety and Efficacy of Devices Delivering Inhaled Antibiotics among Adults with Non-Cystic Fibrosis Bronchiectasis: A Systematic Review and a Network Meta-Analysis Author: Sofia Tejada, Sergio Ramírez-Estrada, Carlos G. Forero, Miguel Gallego, Joan B. Soriano, Pablo A. Cardinal-Fernández, Stephan Ehrmann and Jordi Rello Subject: It remains unknown whether the type of aerosol generating device is affecting efficacy and safety among non-cystic fibrosis bronchiectasis (NCFB) adults. The proposal of this network meta-analysis (NMA) is to evaluate effectiveness and safety of inhaled antibiotics administered via dry powder inhaler (DPI) and via nebulizers (SVN) among adult patients with NCFB. Inclusion criteria were randomized-controlled trials, adults (18 years) with NCFB, and inhaled antibiotics administered via DPI as intervention. Search strategy was performed in PubMed, Web of Science, and Cochrane Library from 2000 to 2019. Sixteen trials (2870 patients) were included. Three trials (all ciprofloxacin) used DPIs and thirteen used SVN (three ciprofloxacin). Both DPI and SVN devices achieved similar safety outcomes (adverse events, antibiotic discontinuation, severe adverse events, and bronchospasm). Administration of ciprofloxacin via DPI significantly improved time to first exacerbation (87 days, 95% CI 34.3 139.7) and quality of life (MD -7.52; 95% CI -13.06 to -1.98) when compared with via SVN. No other significant differences were documented in clinical efficacy (at least one exacerbation, FEV1% predicted) and microbiologic response (bacterial eradication, emergence of new potential pathogens, and emergence of antimicrobial resistance) when comparing devices. Our NMA documented that time to first exacerbation and quality of life, were more favorable for DPIs. Decisions on the choice of devices should incorporate these findings plus other criteria, such as simplicity, costs or maintenance requirements. Keywords: bronchiectasis; non-cystic fibrosis; dry powder inhaled; small-volume nebulizer; inhaled antibiotics Creator: LaTeX with hyperref Producer: pdfTeX-1.40.21 CreationDate: Tue Feb 22 02:44:23 CET 2022 ModDate: Tue Feb 22 02:56:00 CET 2022 ID: 0x21aa76106e267ff6a2663591388d2e0c, 0x21aa76106e267ff6a2663591388d2e0c Filters: FilterPipeline: FlateDecode Fonts: Type1: Font: BaseFont: SSNIUI+VnURWPalladioL-Bold FontSubset: true FirstChar: 161 LastChar: 189 FontDescriptor: FontName: SSNIUI+VnURWPalladioL-Bold Flags: Symbolic FontBBox: -152, -301, 1000, 935 FontFile: true EncodingDictionary: Differences: true Font: BaseFont: NDIIOJ+URWPalladioL-Roma FontSubset: true FirstChar: 2 LastChar: 248 FontDescriptor: FontName: NDIIOJ+URWPalladioL-Roma Flags: Symbolic FontBBox: -166, -283, 1021, 943 FontFile: true EncodingDictionary: Differences: true Font: BaseFont: PYNNNQ+URWPalladioL-BoldItal FontSubset: true FirstChar: 68 LastChar: 118 FontDescriptor: FontName: PYNNNQ+URWPalladioL-BoldItal Flags: Symbolic FontBBox: -170, -300, 1073, 935 FontFile: true EncodingDictionary: Differences: true Font: BaseFont: OXVNHD+URWPalladioL-Ital FontSubset: true FirstChar: 2 LastChar: 121 FontDescriptor: FontName: OXVNHD+URWPalladioL-Ital Flags: Symbolic FontBBox: -170, -305, 1010, 941 FontFile: true EncodingDictionary: Differences: true Font: BaseFont: EIFDAO+VnURWPalladioL FontSubset: true FirstChar: 129 LastChar: 226 FontDescriptor: FontName: EIFDAO+VnURWPalladioL Flags: Symbolic FontBBox: -166, -283, 1021, 943 FontFile: true EncodingDictionary: Differences: true Font: BaseFont: LJEZBI+CMSY10 FontSubset: true FirstChar: 0 LastChar: 21 FontDescriptor: FontName: LJEZBI+CMSY10 Flags: Symbolic FontBBox: -29, -960, 1116, 775 FontFile: true Font: BaseFont: QEEQTI+URWPalladioL-Bold FontSubset: true FirstChar: 2 LastChar: 122 FontDescriptor: FontName: QEEQTI+URWPalladioL-Bold Flags: Symbolic FontBBox: -152, -301, 1000, 935 FontFile: true EncodingDictionary: Differences: true Pages: Page: Sequence: 1 Annotations: Annotation: Subtype: Link Rect: 111, 323, 152, 332 Annotation: Subtype: Link Rect: 34, 311, 149, 320 Annotation: Subtype: Link Rect: 34, 164, 96, 186 Annotation: Subtype: Link Rect: 126, 90, 154, 99 Annotation: Subtype: Link Rect: 34, 78, 147, 87 Annotation: Subtype: Link Rect: 34, 757, 167, 793 Annotation: Subtype: Link Rect: 515, 757, 560, 793 Annotation: Subtype: Link Rect: 110, 642, 121, 655 Annotation: Subtype: Link Rect: 502, 642, 513, 655 Annotation: Subtype: Link Rect: 173, 629, 184, 643 Annotation: Subtype: Link Rect: 382, 629, 393, 643 Annotation: Subtype: Link Rect: 549, 105, 556, 114 ActionDest: 247 Annotation: Subtype: Link Rect: 278, 80, 285, 89 ActionDest: 247 Annotation: Subtype: Link Rect: 288, 80, 295, 89 ActionDest: 250 Annotation: Subtype: Link Rect: 449, 67, 456, 76 ActionDest: 250 Annotation: Subtype: Link Rect: 120, 17, 281, 28 Annotation: Subtype: Link Rect: 400, 17, 560, 28 Annotation: Subtype: Link Rect: 34, 444, 86, 463 Page: Sequence: 2 Annotations: Annotation: Subtype: Link Rect: 471, 723, 478, 732 ActionDest: 250 Annotation: Subtype: Link Rect: 375, 710, 382, 719 ActionDest: 250 Annotation: Subtype: Link Rect: 272, 685, 279, 694 ActionDest: 250 Annotation: Subtype: Link Rect: 216, 647, 228, 657 ActionDest: 250 Annotation: Subtype: Link Rect: 188, 635, 195, 644 ActionDest: 250 Annotation: Subtype: Link Rect: 195, 635, 207, 644 ActionDest: 250 Annotation: Subtype: Link Rect: 210, 635, 222, 644 ActionDest: 250 Annotation: Subtype: Link Rect: 191, 597, 202, 606 ActionDest: 250 Annotation: Subtype: Link Rect: 466, 572, 473, 581 ActionDest: 250 Annotation: Subtype: Link Rect: 247, 509, 254, 519 ActionDest: 250 Annotation: Subtype: Link Rect: 254, 510, 266, 519 ActionDest: 250 Annotation: Subtype: Link Rect: 267, 510, 279, 519 ActionDest: 250 Annotation: Subtype: Link Rect: 217, 447, 229, 456 ActionDest: 250 Annotation: Subtype: Link Rect: 311, 295, 323, 304 ActionDest: 250 Annotation: Subtype: Link Rect: 326, 295, 338, 304 ActionDest: 253 Annotation: Subtype: Link Rect: 213, 270, 225, 279 ActionDest: 250 Annotation: Subtype: Link Rect: 226, 270, 238, 279 ActionDest: 250 Annotation: Subtype: Link Rect: 401, 257, 413, 266 ActionDest: 253 Annotation: Subtype: Link Rect: 414, 257, 426, 266 ActionDest: 253 Annotation: Subtype: Link Rect: 207, 242, 214, 254 ActionDest: 83 Page: Sequence: 3 Annotations: Annotation: Subtype: Link Rect: 365, 181, 377, 190 ActionDest: 250 Annotation: Subtype: Link Rect: 380, 181, 392, 190 ActionDest: 250 Annotation: Subtype: Link Rect: 530, 181, 542, 190 ActionDest: 250 Annotation: Subtype: Link Rect: 542, 181, 554, 190 ActionDest: 250 Annotation: Subtype: Link Rect: 347, 156, 359, 165 ActionDest: 250 Annotation: Subtype: Link Rect: 360, 156, 372, 165 ActionDest: 250 Annotation: Subtype: Link Rect: 374, 156, 386, 165 ActionDest: 253 Annotation: Subtype: Link Rect: 461, 156, 473, 165 ActionDest: 250 Annotation: Subtype: Link Rect: 474, 156, 486, 165 ActionDest: 253 Annotation: Subtype: Link Rect: 241, 144, 253, 153 ActionDest: 250 Annotation: Subtype: Link Rect: 338, 144, 350, 153 ActionDest: 250 Annotation: Subtype: Link Rect: 432, 144, 444, 153 ActionDest: 250 Annotation: Subtype: Link Rect: 241, 128, 248, 140 ActionDest: 113 Page: Sequence: 4 Page: Sequence: 5 Page: Sequence: 6 Annotations: Annotation: Subtype: Link Rect: 250, 703, 262, 712 ActionDest: 253 Annotation: Subtype: Link Rect: 491, 598, 498, 610 ActionDest: 123 Annotation: Subtype: Link Rect: 374, 280, 381, 292 ActionDest: 161 Annotation: Subtype: Link Rect: 476, 242, 483, 254 ActionDest: 161 Annotation: Subtype: Link Rect: 226, 141, 233, 153 ActionDest: 161 Annotation: Subtype: Link Rect: 350, 116, 357, 128 ActionDest: 161 Annotation: Subtype: Link Rect: 414, 104, 421, 116 ActionDest: 161 Page: Sequence: 7 Annotations: Annotation: Subtype: Link Rect: 513, 141, 520, 153 ActionDest: 161 Annotation: Subtype: Link Rect: 460, 90, 467, 103 ActionDest: 207 Page: Sequence: 8 Annotations: Annotation: Subtype: Link Rect: 228, 735, 235, 747 ActionDest: 161 Annotation: Subtype: Link Rect: 330, 722, 337, 734 ActionDest: 161 Annotation: Subtype: Link Rect: 437, 389, 444, 401 ActionDest: 161 Annotation: Subtype: Link Rect: 354, 326, 361, 338 ActionDest: 161 Annotation: Subtype: Link Rect: 324, 165, 336, 174 ActionDest: 253 Annotation: Subtype: Link Rect: 190, 140, 202, 149 ActionDest: 253 Annotation: Subtype: Link Rect: 203, 140, 215, 149 ActionDest: 253 Annotation: Subtype: Link Rect: 401, 102, 413, 111 ActionDest: 253 Annotation: Subtype: Link Rect: 406, 77, 413, 86 ActionDest: 250 Page: Sequence: 9 Annotations: Annotation: Subtype: Link Rect: 363, 499, 375, 508 ActionDest: 253 Annotation: Subtype: Link Rect: 350, 474, 357, 483 ActionDest: 250 Annotation: Subtype: Link Rect: 271, 461, 283, 470 ActionDest: 253 Annotation: Subtype: Link Rect: 284, 461, 296, 470 ActionDest: 253 Annotation: Subtype: Link Rect: 228, 449, 240, 458 ActionDest: 250 Annotation: Subtype: Link Rect: 239, 436, 251, 445 ActionDest: 253 Annotation: Subtype: Link Rect: 214, 336, 226, 345 ActionDest: 253 Annotation: Subtype: Link Rect: 227, 336, 239, 345 ActionDest: 253 Annotation: Subtype: Link Rect: 544, 311, 556, 320 ActionDest: 253 Annotation: Subtype: Link Rect: 411, 298, 423, 307 ActionDest: 253 Annotation: Subtype: Link Rect: 528, 258, 534, 270 ActionDest: 237 Page: Sequence: 10 Annotations: Annotation: Subtype: Link Rect: 400, 662, 412, 671 ActionDest: 253 Annotation: Subtype: Link Rect: 412, 662, 424, 671 ActionDest: 253 Annotation: Subtype: Link Rect: 531, 359, 543, 368 ActionDest: 253 Annotation: Subtype: Link Rect: 543, 359, 555, 368 ActionDest: 253 Annotation: Subtype: Link Rect: 230, 334, 242, 343 ActionDest: 253 Annotation: Subtype: Link Rect: 369, 246, 381, 255 ActionDest: 253 Annotation: Subtype: Link Rect: 215, 89, 222, 98 ActionDest: 250 Page: Sequence: 11 Annotations: Annotation: Subtype: Link Rect: 199, 622, 211, 630 ActionDest: 250 Annotation: Subtype: Link Rect: 211, 622, 223, 630 ActionDest: 250 Annotation: Subtype: Link Rect: 255, 294, 267, 303 ActionDest: 253 Annotation: Subtype: Link Rect: 215, 181, 227, 190 ActionDest: 253 Page: Sequence: 12 Annotations: Annotation: Subtype: Link Rect: 536, 598, 560, 609 Annotation: Subtype: Link Rect: 165, 586, 404, 597 Annotation: Subtype: Link Rect: 460, 167, 498, 178 Annotation: Subtype: Link Rect: 504, 167, 540, 178 Annotation: Subtype: Link Rect: 439, 144, 477, 155 Annotation: Subtype: Link Rect: 483, 144, 519, 155 Annotation: Subtype: Link Rect: 519, 121, 557, 132 Annotation: Subtype: Link Rect: 59, 110, 95, 120 Annotation: Subtype: Link Rect: 109, 76, 146, 86 Page: Sequence: 13 Annotations: Annotation: Subtype: Link Rect: 416, 712, 454, 723 Annotation: Subtype: Link Rect: 100, 678, 137, 689 Annotation: Subtype: Link Rect: 228, 643, 266, 654 Annotation: Subtype: Link Rect: 158, 586, 195, 596 Annotation: Subtype: Link Rect: 95, 552, 133, 562 Annotation: Subtype: Link Rect: 469, 528, 507, 539 Annotation: Subtype: Link Rect: 189, 506, 226, 516 Annotation: Subtype: Link Rect: 233, 506, 269, 516 Annotation: Subtype: Link Rect: 166, 482, 203, 493 Annotation: Subtype: Link Rect: 210, 482, 246, 493 Annotation: Subtype: Link Rect: 131, 460, 168, 470 Annotation: Subtype: Link Rect: 175, 460, 211, 470 Annotation: Subtype: Link Rect: 347, 436, 384, 447 Annotation: Subtype: Link Rect: 246, 401, 284, 412 Annotation: Subtype: Link Rect: 246, 367, 284, 378 Annotation: Subtype: Link Rect: 59, 333, 96, 343 Annotation: Subtype: Link Rect: 520, 298, 557, 309 Annotation: Subtype: Link Rect: 291, 275, 328, 286 Annotation: Subtype: Link Rect: 450, 240, 487, 251 Annotation: Subtype: Link Rect: 318, 217, 355, 228 Annotation: Subtype: Link Rect: 361, 217, 397, 228 Annotation: Subtype: Link Rect: 396, 194, 434, 205 Annotation: Subtype: Link Rect: 440, 194, 476, 205 Annotation: Subtype: Link Rect: 319, 161, 356, 171 Annotation: Subtype: Link Rect: 362, 161, 398, 171 Annotation: Subtype: Link Rect: 113, 126, 150, 136 Annotation: Subtype: Link Rect: 408, 102, 446, 113 Annotation: Subtype: Link Rect: 469, 79, 507, 90 Page: Sequence: 14 Annotations: Annotation: Subtype: Link Rect: 144, 724, 182, 735 Annotation: Subtype: Link Rect: 157, 690, 194, 700 Annotation: Subtype: Link Rect: 319, 666, 521, 677 Annotation: Subtype: Link Rect: 222, 632, 259, 642 Annotation: Subtype: Link Rect: 374, 608, 412, 619 Annotation: Subtype: Link Rect: 418, 608, 454, 619 Annotation: Subtype: Link Rect: 122, 575, 160, 585 Annotation: Subtype: Link Rect: 166, 575, 202, 585 Annotation: Subtype: Link Rect: 192, 539, 230, 550 Annotation: Subtype: Link Rect: 236, 539, 272, 550 Annotation: Subtype: Link Rect: 423, 505, 461, 516 Annotation: Subtype: Link Rect: 478, 470, 515, 481 Annotation: Subtype: Link Rect: 521, 470, 557, 481 Annotation: Subtype: Link Rect: 240, 436, 278, 447 Annotation: Subtype: Link Rect: 403, 401, 441, 412 Annotation: Subtype: Link Rect: 447, 401, 483, 412 Annotation: Subtype: Link Rect: 339, 378, 376, 389 Annotation: Subtype: Link Rect: 383, 378, 419, 389 Annotation: Subtype: Link Rect: 469, 355, 506, 366 Annotation: Subtype: Link Rect: 373, 321, 410, 332 Annotation: Subtype: Link Rect: 438, 286, 475, 297 Annotation: Subtype: Link Rect: 59, 241, 96, 251 Annotation: Subtype: Link Rect: 327, 217, 365, 228 Annotation: Subtype: Link Rect: 371, 217, 407, 228 Annotation: Subtype: Link Rect: 322, 194, 360, 205 Annotation: Subtype: Link Rect: 366, 194, 402, 205 Checksum: 2b0ae092 Type: CRC32 Checksum: 9e78bc1d5442afc8c196b483135f078e Type: MD5 Checksum: 244b9ef59ef6ebacf897dc935b5d4e178911c8ef Type: SHA-1